Ironwood Pharmaceuticals to acquire Swiss biotech company VectivBio

Pallavi Madhiraju- May 22, 2023 0

Ironwood Pharmaceuticals, a gastrointestinal (GI)-focused healthcare company, has agreed to acquire VectivBio Holding AG, a Switzerland-based biotech company, listed on the Nasdaq, for around $1 ... Read More

VectivBio initiates phase 3 trial of apraglutide in patients with short bowel syndrome

pharmanewsdaily- February 3, 2021 0

VectivBio, a leading Swiss biotechnology firm, has announced the commencement of patient dosing in its phase 3 STARS clinical trial. This trial will evaluate the ... Read More

Pfizer wraps up $810m acquisition of Swiss biotech company Therachon

pharmanewsdaily- July 7, 2019 0

Pfizer acquisition of Therachon : US pharma giant Pfizer has completed its previously announced acquisition of Swiss biotech company Therachon, which is focused on rare ... Read More